Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-29

Clinical Trial Update: Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Differin Gel over 12 weeks and Tazorac Cream over 12 weeks, with a 6-week Differin-to-Tazorac switch, in acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Differin Gel (adapalene)
  • Tazorac Cream (tazarotene)

Snippet

Sponsor: Galderma R&D | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED